CRT 2026
Coronary
Jeffrey W. Moses, MD, FSCAI
John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States
Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
David G. Rizik, MD, MSCAI, FACC
Health System Chief of Cardiovascular Service Line, Physician Executive Community Cardiovascular Research
Banner University Medicine, Scottsdale Arizona
Scottsdale, Arizona, United States
Disclosure(s): No financial relationships to disclose
Alfredo E. Rodriguez, MD,PhD
Director Cardiac Unit
Otamendi Hospital
CABA, Buenos Aires, Argentina
Disclosure information not submitted.
Bassem Chehab, MD
Director - Structural Heart Program
Ascension Via Christi
Wichita, Kansas, United States
Disclosure(s): No financial relationships to disclose
Michael S. Lee, MD, FACC, FSCAI
Chief of Cardiology, Interventional Cardiologist
Griffin Hospital
LOS ANGELES, California, United States
Disclosure(s): No financial relationships to disclose